National Psoriasis Foundation

IN THE NEWS

Five scientists each receive $50,000 from National Psoriasis Foundation for promising research  Read more
Isotechnika Inc. Announces Phase 3 ESSENCE Data Meets Primary Endpoint in Psoriasis Read more
SIMPONI (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Read more
Caring for diabetes: Live webcast Tuesday, April 28 Read more
Psoriasis Associated With Diabetes And High Blood Pressure In Women Read more
Health Canada Approves Centocor Ortho Biotech Inc. and Schering-Plough Corporation (SGP)'s SIMPONI(TM) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis; First World Regulatory Approval for SIMPONI  Read more
National Psoriasis Foundation statement on Genentech withdrawing Raptiva Read more
Genentech Announces Voluntary Withdrawal of Raptiva from the U.S. Market Read more
Investigational Anti-TNF Biologic Modestly Helpful in Psoriatic Arthritis Read more
Genetic 'master regulator' in skin formation identified Read more
Psoriasis may reflect systemic inflammation, heart disease Read more
Unraveling psoriasis at a genetic level Read more
AAD: Anti-TNF Therapy Improves Psoriasis and Psoriatic Arthritis Read more
Terri Theisen elected to National Psoriasis Foundation Board of Trustees Read more
Need advocacy for psoriasis research Read more
Low-Dose Acitretin Shown Effective in Nail Psoriasis Read more
New Laser for Psoriasis Aims to Cut Treatment Read more
LeAnn Rimes shares her personal struggle with psoriasis in nation's capital Read more
Congress takes on nation's most prevalent autoimmune disease Read more
Tim Gunn’s Fashion Therapy for Psoriasis Read more
RSS feed

Share

Search   

Copyright ©2008 National Psoriasis Foundation/USA